MedEquities Realty Trust (NYSE:MRT) was downgraded by ValuEngine from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday, May 2nd.
Other research analysts have also issued research reports about the stock. KeyCorp lowered their price objective on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating for the company in a research note on Monday, April 16th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $14.00 target price on shares of MedEquities Realty Trust in a report on Wednesday, February 21st. Zacks Investment Research cut shares of MedEquities Realty Trust from a “buy” rating to a “hold” rating in a report on Wednesday, January 3rd. Citigroup cut their price objective on shares of MedEquities Realty Trust from $12.00 to $10.00 and set a “neutral” rating on the stock in a report on Thursday, March 1st. Finally, B. Riley set a $13.00 target price on shares of MedEquities Realty Trust and gave the company a “buy” rating in a report on Thursday, February 22nd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $12.43.
Shares of MedEquities Realty Trust traded up $0.01, reaching $10.40, during mid-day trading on Wednesday, according to MarketBeat. The company’s stock had a trading volume of 3,297 shares, compared to its average volume of 156,942. MedEquities Realty Trust has a 1-year low of $10.27 and a 1-year high of $10.43. The stock has a market capitalization of $329.07 million, a price-to-earnings ratio of 9.11 and a beta of -0.18.
In related news, Director Bluemountain Capital Managemen sold 91,623 shares of the business’s stock in a transaction dated Tuesday, May 8th. The shares were sold at an average price of $10.25, for a total value of $939,135.75. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders sold a total of 235,786 shares of company stock worth $2,435,627 over the last quarter. Insiders own 2.50% of the company’s stock.
A number of hedge funds have recently made changes to their positions in the stock. Bank of New York Mellon Corp increased its stake in shares of MedEquities Realty Trust by 9.3% during the 3rd quarter. Bank of New York Mellon Corp now owns 117,403 shares of the financial services provider’s stock valued at $1,379,000 after acquiring an additional 9,960 shares during the last quarter. JPMorgan Chase & Co. purchased a new stake in shares of MedEquities Realty Trust during the 3rd quarter worth about $118,000. Wells Fargo & Company MN grew its holdings in shares of MedEquities Realty Trust by 43.4% during the 3rd quarter. Wells Fargo & Company MN now owns 35,366 shares of the financial services provider’s stock worth $416,000 after purchasing an additional 10,700 shares during the period. Cubist Systematic Strategies LLC purchased a new stake in shares of MedEquities Realty Trust during the 3rd quarter worth about $177,000. Finally, Schwab Charles Investment Management Inc. grew its holdings in shares of MedEquities Realty Trust by 69.2% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 776,946 shares of the financial services provider’s stock worth $8,718,000 after purchasing an additional 317,829 shares during the period. 89.09% of the stock is owned by hedge funds and other institutional investors.
About MedEquities Realty Trust
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.